EDSAEdesa Biotech, Inc. · Nasdaq Capital Market
Effective Supply — the real overhang

From what's tradeable today to what's realistically coming. Bigger = more selling pressure ahead.

7.68M
Reported Float
7.68M
Tradeable Now
(estimated float)
7.68M
Effective Supply
16.34M
Fully Diluted
Dilution risk6/10
CONFIDENCE: MEDIUM
ELEVATEDAssessed Jul 14, 2026Trigger: EFFECT registration filingHIGHPreferred stock conversion overhang (fixed, deeply ITM)MODERATEPreferred + warrant overhang (insider, ITM)

Primary driver is ~4.27M shares of deeply in-the-money FIXED-price convertible preferred (Series B-1 at $1.92 and Series A-1 at $3.445 vs ~$7 market) equal to ~55% of the 7.68M float — large potential supply, though tempered by 4.99%/9.99%/19.99% ownership blockers and heavy insider/lead-investor holding (not a death spiral, no variable pricing). Warrant overhang is modest (only 326,560 CEO-held warrants ITM; rest far OTM). Company is actively financing (ATM draws, Feb 2025 and June 2026 PIPEs) with a long reverse-split/serial-raise history. Not variable-rate, so capped below EXTREME.

Share Structure

Float to Fully Diluted Breakdown

LIKELY STALE

Reported float from Insight Sentry. Adjusted based on SEC filing analysis.

Reported Float7.68M47.0%
Warrants745K4.6%
common327K shares at $3.445
common391K shares at $24.64
common27K shares at $31.94
Options / RSUs378K2.3%
Stock Options378K shares
≈ Estimated Actual Float

Reported float + filing adjustments

7.68M

MEDIUM confidence

Pending Shares as % of Float87.3%

Registered and convertible shares that could enter the float relative to current float size.

Fully Diluted16.34M100%

Share estimates are approximate. Convertible share counts based on current price. Review SEC filings for exact terms.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue
Dilution profile
Reverse splits (4)
  • 1-for-7·Oct 11, 2023~3 yr ago
  • 1-for-6·Jun 10, 2019~7 yr ago
  • 1-for-7·May 7, 2018~8 yr ago
  • 1-for-10·Sep 2, 2015~11 yr ago
Active mechanisms
  • HCW ATM (~$2.26M remaining, active)
  • Series B-1 convertible preferred (736 shares → ~3.83M common at $1.92 fixed, ITM)
  • Series A-1 convertible preferred (150 shares → ~435K common at $3.445 fixed, ITM)
  • ITM CEO warrants (326,560 at $3.445)
  • $150M S-3 shelf (baby-shelf limited)
  • Vested RSUs (751,473 of 1,313,069)

Market Data

Price

$5.25

Market Cap

$50.57M

Outstanding

9.63M

Float

7.68M

Avg Volume

59.0K

Exchange: NASDAQ|Source: Insight Sentry